文献速递肝胆胰外科围术期管理与 ERAS

肝细胞癌肝切除术后血清转氨酶水平的围术期变化:对术后并发症的影响

Perioperative Changes in Serum Transaminase Levels: Impact on Postoperative Morbidity After Liver Resection of Hepatocellular Carcinoma.
PubMed 文献 · Ann Surg · 2024-02-13

基于国际多机构数据库2010至2020年759例肝细胞癌根治性肝切除患者,计算术后第3天与术前AST和ALT的融合指数变化(CAA)。CAA与综合并发症指数呈非线性递增关联,CAA≥5与术后并发症风险独立相关(比值比1.63,95%CI 1.05-2.55,P=0.03)。

要点

  • CAA是肝细胞癌肝切除术后综合并发症指数的独立预测因子。
  • CAA≥5与术后并发症风险相关,比值比1.63(95%CI 1.05-2.55,P=0.03)。
  • 常规实验室AST和ALT可用于识别肝细胞癌切除术后并发症高风险患者。

核心结论

  • CAA是肝细胞癌肝切除术后综合并发症指数的独立预测因子。
  • 使用AST和ALT等常规实验室检查有助于识别肝细胞癌切除术后并发症风险最高的患者。

研究设计与样本

  • 从国际多机构数据库中识别2010至2020年间接受肝细胞癌根治性切除的患者。
  • 分析队列共纳入759例患者。
  • 计算术后第3天与术前AST和ALT值的变化(CAA),采用基于欧几里得范数的融合指数公式,并相对于综合并发症指数(CCI)进行分析。
  • 采用限制性立方样条回归和随机森林分析评估CAA对CCI的影响。

主要发现

  • CAA中位值为1.7(范围:0.9-3.25);431例(56.8%)患者CAA<2,215例(28.3%)患者CAA为2至5,113例(14.9%)患者CAA≥5。
  • 术后并发症发生率为65.0%(n=493),CCI中位值为20.9(四分位距:20.9-33.5)。
  • 样条回归分析显示CAA与CCI之间存在非线性递增关联。
  • 递归分割技术确定CAA的最佳截断值为5。
  • 调整其他竞争风险因素后,CAA≥5仍与术后并发症风险强烈相关(参照CAA<5,比值比:1.63,95%CI:1.05-2.55,P=0.03)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To define how dynamic changes in pre versus postoperative serum aspartate aminotransferase (AST) and alanine transaminase (ALT) levels may impact postoperative morbidity after curative-intent resection of hepatocellular carcinoma (HCC). BACKGROUND: Hepatic ischemia/reperfusion can occur at the time of liver resection and may be associated with adverse outcomes after liver resection. METHODS: Patients who underwent curative resection for HCC between 2010 and 2020 were identified from an international multi-institutional database. Changes in AST and ALT (CAA) on postoperative day 3 versus preoperative values ( ) were calculated using the formula: based on a fusion index through the Euclidean norm, which was examined relative to the Comprehensive Complication Index (CCI). The impact of CAA on CCI was assessed by the restricted cubic spline regression and Random Forest analyses. RESULTS: A total of 759 patients were included in the analytic cohort. Median CAA was 1.7 (range: 0.9-3.25); 431 (56.8%) patients had a CAA <2 215 (28.3%) patients with CAA 2 to 5, and 113 (14.9%) patients had CAA ≥5. The incidence of postoperative complications was 65.0% (n = 493) with a median CCI of 20.9 (interquartile range: 20.9-33.5). Spline regression analysis demonstrated a nonlinear incremental association between CAA and CCI. The optimal cutoff value of CAA was 5, identified by the recursive partitioning technique. After adjusting for other competing risk factors, CAA ≥5 remained strongly associated with the risk of postoperative complications (reference CAA <5, odds ratio: 1.63, 95% CI: 1.05-2.55, P = 0.03). In fact, the use of CAA to predict postoperative complications was very good in both the derivative (area under the curve: 0.88) and external (area under curve: 0.86) cohorts (n = 1137). CONCLUSIONS: CAA was an independent predictor of CCI after liver resection for HCC. The use of routine laboratories, such as AST and ALT, can help identify patients at the highest risk of postoperative complications after HCC resection.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Wang F, Lu J, Yang T, et al. Perioperative Changes in Serum Transaminase Levels: Impact on Postoperative Morbidity After Liver Resection of Hepatocellular Carcinoma. Ann Surg. 2024. PMID: 38348655. doi:10.1097/SLA.0000000000006235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。